<abstract xmlns="http://www.w3.org/1999/xhtml">The Rh blood group antigen e is of high incidence and has many epitopes. Partial expression may occur, more commonly in black persons. Individuals with e variant phenotypes can make antibodies to epitopes they lack. While some of these antibodies may be specific for an antigen, e.g., hrB, others, like anti-Rh17 (anti-Hro), show broader specificity, compatible only with D–– and Rhnull red blood cells (RBCs). Anti-Rh17 in persons of the D–– phenotype has been reported to cause mild to fatal HDN. We report an example of anti-Rh17 produced by a black female with an e variant RBC phenotype that caused moderate HDN. A panel of seven monoclonal anti-e demonstrated her RBCs carried a variant e antigen, and her genotype was <italic>RHD, RHce</italic> by PCR-RFLP analysis. Amniotic fluid with ΔOD450 values from 30 to 35 weeks’ gestation predicted moderate HDN probability by the Liley method. At 38+ weeks, a viable 3165 g female infant was delivered. The infant’s direct antiglobulin test was 2+ with anti-IgG. Total bilirubin rose to 14.2 mg/dL within 48 hours. Indirect bilirubin peaked at 14.7 mg/dL. The bilirubin responded to triple phototherapy. The infant was discharged on day 6. Potential for infant morbidity due to anti-Rh17-mediated HDN and the importance of specifying risks to women with this antibody if they contemplate pregnancy are discussed. <bold><italic>Immunohematology</italic> 2002:18:40–42</bold>.</abstract>

The Rh blood group antigen e is of high incidence and has many epitopes. Partial expression may occur, more commonly in black persons. Individuals with e variant phenotypes can make antibodies to epitopes they lack. While some of these antibodies may be specific for an antigen, e.g., hrB, others, like anti-Rh17 (anti-Hro), show broader specificity, compatible only with D–– and Rhnull red blood cells (RBCs). Anti-Rh17 in persons of the D–– phenotype has been reported to cause mild to fatal HDN. We report an example of anti-Rh17 produced by a black female with an e variant RBC phenotype that caused moderate HDN. A panel of seven monoclonal anti-e demonstrated her RBCs carried a variant e antigen, and her genotype was RHD, RHce by PCR-RFLP analysis. Amniotic fluid with ΔOD450 values from 30 to 35 weeks’ gestation predicted moderate HDN probability by the Liley method. At 38+ weeks, a viable 3165 g female infant was delivered. The infant’s direct antiglobulin test was 2+ with anti-IgG. Total bilirubin rose to 14.2 mg/dL within 48 hours. Indirect bilirubin peaked at 14.7 mg/dL. The bilirubin responded to triple phototherapy. The infant was discharged on day 6. Potential for infant morbidity due to anti-Rh17-mediated HDN and the importance of specifying risks to women with this antibody if they contemplate pregnancy are discussed. Immunohematology 2002:18:40–42.

Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype

Immunohematology

The Rh blood group antigen e is of high incidence and has many epitopes. Partial expression may occur, more commonly in black persons. Individuals with e...

Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype

Pubblicato online: 14 ott 2020

Pagine: 40 - 42

DOI: https://doi.org/10.21307/immunohematology-2019-507

Parole chiave
hemolytic disease of the newborn (HDN), anti-Rh17, variant e phenotype

© 2002 M.C Brumit et al., published by Sciendo

Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype

Pubblicato online: 14 ott 2020

Pagine: 40 - 42

DOI: https://doi.org/10.21307/immunohematology-2019-507

Parole chiavehemolytic disease of the newborn (HDN), anti-Rh17, variant e phenotype

© 2002 M.C Brumit et al., published by Sciendo

Parole chiave
hemolytic disease of the newborn (HDN), anti-Rh17, variant e phenotype